Suppr超能文献

常见的丙氨酸4突变为缬氨酸的超氧化物歧化酶-1突变与快速进展性家族性肌萎缩侧索硬化症相关。

A frequent ala 4 to val superoxide dismutase-1 mutation is associated with a rapidly progressive familial amyotrophic lateral sclerosis.

作者信息

Rosen D R, Bowling A C, Patterson D, Usdin T B, Sapp P, Mezey E, McKenna-Yasek D, O'Regan J, Rahmani Z, Ferrante R J

机构信息

Day Neuromuscular Research Laboratory, Massachusetts General Hospital, Charlestown 02129-2060.

出版信息

Hum Mol Genet. 1994 Jun;3(6):981-7. doi: 10.1093/hmg/3.6.981.

Abstract

Familial amyotrophic lateral sclerosis (FALS), a degenerative disorder of motor neurons, is associated with mutations in the Cu/Zn superoxide dismutase gene SOD1 in some affected families. We confirm a recently reported ala4-->val mutation in exon 1 of the SOD1 gene and report that this mutation is both the most commonly detected of all SOD1 mutations and among the most clinically severe. By comparison with our other FALS families, the exon 1 mutation is associated with reduced survival time after onset: 1.2 years, as compared to 2.5 years for all other FALS patients. We also demonstrate that SOD1 is prominently expressed in normal motor neurons and that neural expression of SOD1 is not prevented by this exon 1 mutation. Assays of SOD1 enzymatic activity in extracts from red blood cells, lymphoblastoid cells, and brain tissues revealed an approximately 50% reduction in activity of cytosolic SOD1 in patients with this mutation compared to normal individuals. By contrast, patients with sporadic ALS had normal levels of SOD1 enzymatic activity. Why this SOD1 mutation causes motor neuron death in FALS remains to be established. While it may be that FALS is a consequence of loss of SOD1 function, it is also possible that motor neuron death in this dominantly inherited disease occurs because the mutations confer an additional, cytotoxic function on the SOD1 protein.

摘要

家族性肌萎缩侧索硬化症(FALS)是一种运动神经元退行性疾病,在一些患病家族中与铜/锌超氧化物歧化酶基因SOD1的突变有关。我们证实了最近报道的SOD1基因第1外显子中的ala4→val突变,并报告该突变是所有SOD1突变中最常检测到的,也是临床症状最严重的突变之一。与我们研究的其他FALS家族相比,第1外显子突变与发病后存活时间缩短有关:为1.2年,而其他所有FALS患者为2.5年。我们还证明,SOD1在正常运动神经元中显著表达,并且该第1外显子突变并不影响SOD1在神经中的表达。对红细胞、淋巴母细胞和脑组织提取物中SOD1酶活性的检测显示,与正常个体相比,该突变患者胞质SOD1的活性降低了约50%。相比之下,散发性肌萎缩侧索硬化症患者的SOD1酶活性水平正常。这种SOD1突变为何会导致FALS中的运动神经元死亡仍有待确定。虽然FALS可能是SOD1功能丧失所致,但在这种常染色体显性遗传病中,运动神经元死亡也可能是因为这些突变赋予了SOD1蛋白一种额外的细胞毒性功能。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验